Medical Facilities Corporation ( DR:CA) Q4 2025 Earnings Call March 12, 2026 8:30 AM EDT Good morning, everyone. Welcome to Medical Facilities Corporation's 2025 Fourth Quarter and Year-End Results ...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced new open-label extension study data for repinatrabit (JNT-517), demonstrating ...

GLP-1 drugs like Ozempic have long helped people eat less — now, they’re showing promise in helping people crave less.

Medical insurance eligibility and benefits verification (EBV) is a core health technology capability necessary for ...

The new Health AI answers questions, explains health records, manages prescription renewals, books appointments, and more.

New York City's new health commissioner, Alister Martin, MD, is stepping into the role at a time of growing tension between local public health officials and federal policy.

Compare the top 10 hair transplant clinics in Turkey. We reveal real U.S. vs. Turkey costs, advanced techniques, and 3 red flags to avoid.

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, payers and other industry players look to expand their businesses and gain a competitive edge. | CHS' ...

Peptilogics' PLG0206 is a first-in-class anti-biofilm drug candidate being studied in patients with prosthetic joint infection (PJI), the first of multiple potential medical device-related infections ...

As a physician who prescribes GLP-1 medications like Ozempic, Wegovy, semaglutide, and tirzepatide, I explain why increasing ...

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301Proprietary Forzet formulation provides ...